Polypeptide, dna fragment encoding the same, drug...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/15 (2006.01) A61K 38/02 (2006.01) A61K 38/57 (2006.01) C07K 2/00 (2006.01) C07K 14/81 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2082226

ABSTRACT OF THE INVENTION This invention particularly provides a novel polypeptide having high protease-inhibiting activity, preferably FXa- inhibiting activity, which comprises, at least as a part of the polypeptide, an amino acid sequence resulting from substitution of an amino acid for at least one amino acid in the following amino acid sequence (1), wherein the amino acid substitution is at least one substitution selected from the following substitution means (i) to (iii). It also provides a process for the production of the polypeptide, a novel DNA fragment encoding the polypeptide and a drug composition containing the same. Amino acid sequence (1) Image (i) Substitution of 15 position Gln counting from the N- terminus by an amino acid other than Gln. (ii) Substitution of 42 position Tyr counting from the N- terminus by an amino acid other than Tyr. (iii) Substitution of 7 position Arg counting from the N- terminus by an amino acid other than Arg.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Polypeptide, dna fragment encoding the same, drug... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polypeptide, dna fragment encoding the same, drug..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptide, dna fragment encoding the same, drug... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1767066

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.